研發團隊
在實驗室主持人張家榮博士與吳佩穎博士的領導下，瑞寶基因擁有一支實力堅強的研發團隊，為公司開發優質疫苗產品提供了關鍵技術支撐。團隊成員多具生物技術、動物科學及獸醫等相關領域碩士學歷，並累積多年生技產業經驗，展現出深厚的科研實力與高效率的研發能量。這支技術核心團隊，正是瑞寶基因得以成為臺灣少數同時具備疫苗「研發」與「生產」能力之動物疫苗公司的重要基石。
瑞寶基因所建構之專利技術平台，不僅是研發工作的核心支柱，更是我們在動物疫苗領域穩固立足、持續創新的關鍵優勢。為加速疫苗產品的開發與製程優化，我們積極與多家國內頂尖研發機構及學術單位建立策略合作夥伴關係，包括農業科技研究院、家畜衛生試驗所、中央研究院、國立臺灣大學、嘉義大學、中興大學、屏東科技大學、中國醫藥大學、交通大學與清華大學等。
無論是透過技術授權、聯合研發或產學合作，瑞寶基因皆已取得多項具體成果，充分展現我們在疫苗研發與技術整合方面的領導實力與前瞻視野。
發表文獻
1.Taehwan Oh, Hanjin Kim, Kee Hwan Park, Jiwoon Jeong, Siyeon Yang, Ikjae Kang, Su-Jin Park, and Chanhee Chae. 2019. A comparative study of the efficacy of a porcine reproductive and respiratory syndrome subunit and a modified-live virus vaccine against respiratory diseases in endemic farms. Can J Vet Res. 83(2): 110–121
2.Taehwan Oh, Hanjin Kim, Kee Hwan Park, Jiwoon Jeong, Ikjae Kang, Siyeon Yang, Chanhee Chae. 2019. Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts. Can J Vet Res. 83(4): 248–254.
3. Jiwoon Jeong , Seeun Kim , Changhoon Park , Ikjae Kang , Kee Hwan Park , Hee Jin Ham , Chanhee Chae. 2018 Effect of Vaccination With a Porcine Reproductive and Respiratory Syndrome Subunit Vaccine on Sow Reproductive Performance in Endemic Farms. Vet Rec. 26;182(21):602
4. Do Tien Duy, Hanjin Kim, Jiwoon Jeong, Kee Hwan Park, Siyeon Yang, Taehwan Oh, Seeun Kim, Ikjae Kang, and Chanhee Chae. 2018. Comparative evaluation of the efficacy of commercial and prototype PRRS subunit vaccines against an HP-PRRSV challenge. J Vet Med Sci. 80(9): 1463–1467.
5. Jiwoon Jeong, Changhoon Park, Kyuhyung Choi, and Chanhee Chae. 2017. Can J Vet Res. Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus. Can J Vet Res. 81(1): 12–21.